Clinical Trials: COVID-19 vaccine generates immune structures critical for lasting immunity
The first two COVID-19 vaccines authorized for emergency use by the Food and Drug Administration (FDA) employed a technology that had never before been used in FDA-approved vaccines. Both vaccines performed well in clinical trials, and both have been widely credited with reducing disease, but concerns remain over how longContinuar Leyendo















